How much profit has Kindred Biosciences made this year?
Kindred Biosciences has made 0 USD this year.
Kindred Biosciences Net Income 2024
Kindred Biosciences Net Income
0 USD
Kindred Biosciences Dividend yield
Ticker
KIN
ISIN
US4945771099
WKN
A1XA6K
In 2024, Kindred Biosciences's profit amounted to 0 USD, a 0% increase from the 0 USD profit recorded in the previous year.
The Kindred Biosciences Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2024e | - |
| 2023e | - |
| 2022e | - |
| 2021e | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
| 2014 | - |
| 2013 | - |
| 2012 | - |
Kindred Biosciences Aktienanalyse
What does Kindred Biosciences do?
Kindred Biosciences Inc. is a biopharmaceutical company that was founded in 2012 by Richard Chin, an experienced pharmaceutical entrepreneur. The company's goal is to develop and bring to market innovative animal medicines for pets. The business model of Kindred Biosciences is based on the identification and development of novel, safe, and effective animal medicines for dogs, cats, and horses. The company utilizes state-of-the-art technologies and research methods to develop high-quality products that meet the needs of veterinarians and pet owners. The company currently has three main business segments: biologics, biopharmaceuticals, and small molecules. Each of these segments focuses on specific animal diseases and offers a unique range of products. The biologics segment of Kindred Biosciences develops innovative vaccines for dogs and cats that are highly effective and have improved tolerability. Kindred Biosciences' vaccines are specifically tailored to the needs of pets and can help prevent infections and diseases in dogs and cats. The biopharmaceuticals segment of Kindred Biosciences develops novel therapies for chronic diseases in dogs and cats, such as chronic pain, inflammation, and cancer. The company utilizes state-of-the-art technologies and research methods to develop effective and safe therapies that meet the needs of veterinarians and pet owners. The small molecules segment of Kindred Biosciences develops novel drugs for horses that are highly effective and have improved tolerability. Kindred Biosciences' drugs are specifically tailored to the needs of horses and can help treat various conditions such as arthritis or colic. The company has a broad range of products, currently consisting of over a dozen products that focus on different animal species, diseases, and needs. These include therapies for chronic pain, inhalation anesthetics, drugs for cancer and inflammation, as well as vaccines for various infections. Kindred Biosciences has achieved significant success in recent years. The company has conducted numerous clinical trials and brought several drugs and vaccines to market. In 2018, the company received approval from the Food and Drug Administration (FDA) for a groundbreaking therapy for chronic pain in dogs. The company also has a strong pipeline of products in development that could contribute to supporting the company's growth in the coming years. In summary, Kindred Biosciences is an innovative biopharmaceutical company focused on the development and commercialization of innovative animal medicines. The company has a broad range of products and is capable of developing high-quality products for a variety of animal species, diseases, and needs. With a strong pipeline and a successful track record, Kindred Biosciences is well-positioned to solidify its leading position in the industry and accelerate its growth in the coming years. Kindred Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Kindred Biosciences's Profit Margins
The profit margins of Kindred Biosciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Kindred Biosciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Kindred Biosciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Kindred Biosciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Kindred Biosciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Kindred Biosciences Stock
How has the profit developed compared to last year?
The profit has increased by 0% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Kindred Biosciences publish its earnings?
Kindred Biosciences publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Kindred Biosciences?
The profits of Kindred Biosciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Kindred Biosciences?
You can learn more about the earnings of Kindred Biosciences by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Kindred Biosciences pay?
Over the past 12 months, Kindred Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Kindred Biosciences is expected to pay a dividend of 0 USD.
What is the dividend yield of Kindred Biosciences?
The current dividend yield of Kindred Biosciences is .
When does Kindred Biosciences pay dividends?
Kindred Biosciences pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Kindred Biosciences?
Kindred Biosciences paid dividends every year for the past 0 years.
What is the dividend of Kindred Biosciences?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Kindred Biosciences located?
Kindred Biosciences is assigned to the 'Health' sector.
Wann musste ich die Aktien von Kindred Biosciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kindred Biosciences from 5/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.
When did Kindred Biosciences pay the last dividend?
The last dividend was paid out on 5/21/2024.
What was the dividend of Kindred Biosciences in the year 2023?
In the year 2023, Kindred Biosciences distributed 0 USD as dividends.
In which currency does Kindred Biosciences pay out the dividend?
The dividends of Kindred Biosciences are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Kindred Biosciences stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Kindred Biosciences
Our stock analysis for Kindred Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kindred Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Kindred Biosciences Revenue
- Kindred Biosciences Net Income
- Kindred Biosciences P/E
- Kindred Biosciences P/S
- Kindred Biosciences EBIT
- Kindred Biosciences Dividend
- Kindred Biosciences Stocks
- Kindred Biosciences Market capitalization
- Kindred Biosciences Debt
- Kindred Biosciences Liabilities
- Kindred Biosciences Equity
- Kindred Biosciences AAQS
- Kindred Biosciences Employees
- Kindred Biosciences ROE
- Kindred Biosciences ROA
- Kindred Biosciences ROCE
